Behzad Aghazadeh

Director

Director at Scribe Therapeutics, Inc., filing insider transactions between 2026-07-24 and 2026-07-28.

Total Purchases

$36.3M

3 transactions

Total Sales

—

0 transactions

Companies Traded

1

3 total filings

Active Since

2026-07-24

Last: 2026-07-28

Companies

Scribe Therapeutics, Inc.

Other Reporting Insiders at Scribe Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-28	SCTX	Purchase	7,905	$18.25	$144K	3.09M	SEC ↗
2026-07-24	SCTX	Purchase	2.33M	$15.00	$35.0M	3.03M	SEC ↗
2026-07-24	SCTX	Purchase	50.0K	$22.31	$1.1M